
    
      The screening visit was performed 2 to 21 days before the first administration of study
      medication, the treatment phase consisted of 12 days (of which study medication was
      administered during the first 8 days), and the follow-up visit was performed 15 to 19 days
      after the first administration of study medication.
    
  